5-Methylheptan-3-one oxime
Common Name: |
5-Methylheptan-3-one oxime |
IUPAC Name: |
N-(5-methylheptan-3-ylidene)hydroxylamine |
Molecular Formula: |
C8H17NO |
SMILES: |
CCC(C)CC(=NO)CC |
Inchi: |
1S/C8H17NO/c1-4-7(3)6-8(5-2)9-10/h7,10H,4-6H2,1-3H3 |
Inchi Key: |
CBVWMGCJNPPAAR-UHFFFAOYSA-N |
Cas No: |
22457-23-4 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
143.23 |
Mass (g/mol) |
143.131 |
Molar Refractivity |
44.98 |
Net Charge |
|
HBD |
1 |
HBA |
2 |
Rt Bonds |
4 |
Rings |
|
TPSA |
32.59 |
Hetero Atoms |
2 |
Heavy Atoms |
10 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
0.041000 |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.88 |
LogP |
2.663 |
iLOGP |
2.25 |
XLOGP3 |
2.48 |
WLOGP |
2.66 |
MLOGP |
1.96 |
ESOL Log S |
-2.03 |
ESOL Solubility (mg/ml) |
1.35 |
ESOL Solubility (mol/l) |
0.009 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.81 |
Ali Solubility (mg/ml) |
0.22 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.80 |
Silicos-IT Solubility (mg/ml) |
2.28 |
Silicos-IT Solubility (mol/l) |
0.02 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.41 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.476 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
1 |
Acute Oral Toxicity |
1.874 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |